Chemoprevention agents to reduce mammographic breast density in premenopausal women: A systematic review of clinical trials

Authors

Ana S. Salazar, Washington University School of Medicine in St. Louis
Malika Rakhmankulova, Washington University School of Medicine in St. Louis
Laura E. Simon, Washington University School of Medicine in St. Louis
Adetunji T. Toriola, Washington University School of Medicine in St. Louis

Journal

JNCI Cancer Spectrum

Publication Date

2021

Volume

5

Issue

1

First Page

pkaa125

Document Type

Open Access Publication

DOI

10.1093/jncics/pkaa125

Rights and Permissions

Ana S Salazar, MD, MPHS, Malika Rakhmankulova, MD, MPHS, Laura E Simon, MLIS, Adetunji T Toriola, MD, PhD, MPH, Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials, JNCI Cancer Spectrum, Volume 5, Issue 1, February 2021, pkaa125, https://doi.org/10.1093/jncics/pkaa125. © The Author(s) 2021. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. https://academic.oup.com/jncics/article/5/1/pkaa125/6108103.

Recommended Citation

Salazar, Ana S.; Rakhmankulova, Malika; Simon, Laura E.; and Toriola, Adetunji T., "Chemoprevention agents to reduce mammographic breast density in premenopausal women: A systematic review of clinical trials." JNCI Cancer Spectrum. 5, 1. pkaa125 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10120